# clm_25811D4BA2CF

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: quarterly_net_income  
value: 2,592,000,000 United States dollar  
valid_from: 2021-09-30  
valid_to: 2022-03-31  
published: 2021-11-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_B63753C50038  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences quarterly net income: 2,592,000,000 United States dollar", as of 2021-09-30 (until 2022-03-31). Claim clm_25811D4BA2CF, https://asof.is/claim/clm_25811D4BA2CF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209521000029/0000882095-21-000029-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q3 FY2021, filed 2021-11-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209521000029/0000882095-21-000029-index.htm (primary, SEC EDGAR 10-Q Q3 FY2021, published 2021-11-03)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | quarterly_net_income | 1,522,000,000 United States dollar | valid 2021-06-30 to 2021-09-30 | conf 0.95 | superseded | superseded_by [clm_25811D4BA2CF](/claim/clm_25811D4BA2CF.md) | [clm_1E4391435E59](/claim/clm_1E4391435E59.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.